Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

Rapsyn mutations in 16 unrelated patients with a congenital/hereditary myasthenic syndrome were identified, and a mutation (N88K) common to each of them was found. Two distinct phenotypes were noted: early and late onset. The former is frequently associated with arthrogryposis multiplex congenita an...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Burke, G, Cossins, J, Maxwell, S, Owens, G, Vincent, A, Robb, S, Nicolle, M, Hilton-Jones, D, Newsom-Davis, J, Palace, J, Beeson, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	2003

Documenti analoghi

Congenital myasthenia - Rapsyn deficiency: How rare?
di: Burke, G, et al.
Pubblicazione: (2003)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
di: Palace, J
Pubblicazione: (2010)

Distinct phenotypes of congenital acetylcholine receptor deficiency.
di: Burke, G, et al.
Pubblicazione: (2004)

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations
di: Cossins, J, et al.
Pubblicazione: (2006)

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.
di: Cossins, J, et al.
Pubblicazione: (2006)

3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.
di: Palace, J, et al.
Pubblicazione: (1991)

Hereditary and Autoimmune Myasthenias
di: Beeson, D
Pubblicazione: (2013)

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
di: Losen, M, et al.
Pubblicazione: (2005)

CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
di: Müller, J, et al.
Pubblicazione: (2006)

"THE EYES HAVE IT": INITIAL GENETIC SCREENING IN SUSPECTED CONGENITAL MYASTHENIA
di: Lashley, D, et al.
Pubblicazione: (2010)

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
di: Palace, J, et al.
Pubblicazione: (1998)

FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
di: Finlayson, S, et al.
Pubblicazione: (2012)

Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
di: Martínez-Martínez, P, et al.
Pubblicazione: (2007)

The management of myasthenia gravis
di: Hilton-Jones, D, et al.
Pubblicazione: (2005)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
di: Man, S, et al.
Pubblicazione: (2005)

Myasthenia gravis: diagnostic and management dilemmas.
di: Palace, J, et al.
Pubblicazione: (2001)

Myasthenia gravis.
di: Vincent, A, et al.
Pubblicazione: (2001)

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
di: Cossins, J, et al.
Pubblicazione: (2010)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
di: Burke, G, et al.
Pubblicazione: (2006)

The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells
di: Spearman, H, et al.
Pubblicazione: (2008)

Clinical features in a series of fast channel congenital myasthenia syndrome.
di: Palace, J, et al.
Pubblicazione: (2012)

Clinical features in a series of fast channel congenital myasthenia syndrome.
di: Palace, J, et al.
Pubblicazione: (2012)

Antibodies to AChRs in seronegative myasthenia gravis
di: Leite, M, et al.
Pubblicazione: (2006)

Clinical features of the DOK7 neuromuscular junction synaptopathy.
di: Palace, J, et al.
Pubblicazione: (2007)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
di: Palace, J, et al.
Pubblicazione: (2004)

Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
di: Croxen, R, et al.
Pubblicazione: (2002)

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis
di: Palace, J, et al.
Pubblicazione: (1998)

The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
di: Beeson, D, et al.
Pubblicazione: (2012)

Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.
di: Glennerster, A, et al.
Pubblicazione: (1996)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
di: McConville, J, et al.
Pubblicazione: (2002)

The search for new antigenic targets in myasthenia gravis.
di: Cossins, J, et al.
Pubblicazione: (2012)

Myasthenia gravis seronegative for acetylcholine receptor antibodies.
di: Vincent, A, et al.
Pubblicazione: (2008)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
di: Lashley, D, et al.
Pubblicazione: (2009)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
di: Xufeng Liao, et al.
Pubblicazione: (2023-09-01)

Prevalence and geographical distribution of UK congenital myasthenic syndrome patients referred to the oxford national specialist commissioning advisory group service
di: Lashley, D, et al.
Pubblicazione: (2007)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
di: McConville, J, et al.
Pubblicazione: (2004)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
di: Beeson, D, et al.
Pubblicazione: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
di: Beeson, D, et al.
Pubblicazione: (2008)

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
di: Farrugia, M, et al.
Pubblicazione: (2007)

Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis
di: Leite, M, et al.
Pubblicazione: (2007)